3Terasawa H,Tsang KY,Gulley J,et al.Identification and characterization of a human agonist cytotoxic T lymphocyte epitope of human prostate -specific antigen[J].Clin Cancer Res,2002,8(1):41-45.
4Huggins C,Hodges CV.Studies on prostatic cancer:The effect of castration,of estrogen and of androgen injection on the serum phosphatases in metastatic carcinoma of prostate[J].J Urol,2002,168(1):9-12.
5Chen CD,Welsbie DS,Tran C,et al.Molecular determinants of resistance to antiandrogen therapy[J].Nat Med,2004,10(1):33-39.
7Madan RA,Aragon-Ching JB,Gulley JL,et al.From clinical trials to clinical practice:therapeutic cancer vaccines for the treatment of prostate cancer[J].Expert Rev Vaccines,2011,10(6):743-753.
8Mabjeesh NJ,Zhong H,Simons JW.Gene therapy of prostate cancer:current and future directions[J].Endocr Relat Cancer,2002,9(2):115-139.
9Marxa L Figueiredo,Chinghai Kao,Lily Wu.Advance in preclinical investigation of prostate cancer gene therapy[J].Mol Ther,2007,15 (6):1053-1064.
10Salgia R,Lynch T,Skarin A,et al.Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma[J].J Clin Oncol,2003,21(4):624-630.
